✦ LIBER ✦
88 Oral etoposide (VP-16) every 3 wks. or continuously to elderly patients with small cell lung cancer (SCLC): Preliminary results of a randomized study
✍ Scribed by Bork, E.; Hirsch, F.; Jeppesen, N.; Lassen, U.; Vallentin, S.; Østerlind, K.; Mejer, J.; Ingeberg, S.; Bergman, B.; Dombernowsky, P.
- Book ID
- 122837261
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 132 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.